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Abstract: Information on retroviruses infections in great apes is scarce, especially for apes kept in sanctuaries throughout 
Africa. To investigate the prevalence of retroviruses and possible transmission of different retroviruses originating from 
chimpanzees of different origin (Uganda, Congo and Rwanda), 38 wild-born captive orphan chimpanzees residing in a 
sanctuary on Ngamba Island were analyzed for retroviral infections. Samples from sanctuary chimpanzees were analyzed 
using enzyme-linked immunoassays and polymerase chain reactions (PCR). Viruses were characterized by phylogenetic 
analysis. All chimpanzees were negative for antibodies against Simian Immunodeficiency Virus (SIV) and Simian T-cell 
Leukemia Virus (STLV). However, 28/38 (73%) chimpanzees were positive to Simian Foamy Virus (SFV) by analysis of 
a 425-bp DNA segment obtained by PCR using generic integrase primers homologous to highly conserved portions of the 
polymerase gene. Phylogenetic analysis of SFV sequences obtained in this study formed four sub clusters within the 
specific SFV P. t. schweinfurthii clade with significant variability among the new SFVs strains. 
We provide evidence of on-going cross-transmission of SFV among chimpanzees within the sanctuary mostly likely 
through horizontal routes. We propose to test all chimpanzees introduced into sanctuaries for retroviral and other 
infections. This will help avoid the spread also of pathogenic viruses in captive populations. 
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INTRODUCTION 
 Simian Immunodeficiency Virus (SIV), Simian T-cell 
Leukemia Virus (STLV) and Simian Foamy Virus (SFV) are 
known to occur in wild populations of chimpanzees. 
However, the prevalence of these viruses varies 
significantly. SIV is found only in some specific groups of 
wild chimpanzees with low prevalence within the group [1, 
2]. SFV in contrast was present in all wild chimpanzee 
groups studied. The prevalence rates ranged from 44% to 
100% with several individuals infected with more than one 
strain [3, 4]. An age-dependent prevalence was revealed, 
with older individuals showing a higher prevalence [4]. Not 
much is known about the prevalence of STLV in wild 
chimpanzees. Data from Côte d’Ivoire suggest a significantly 
higher prevalence among chimpanzees older than nine years 
with a seroprevalence of 71.4% compared to 9.7% in 
individuals younger than nine years [5]. 
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 To understand the age distribution of animals brought to 
chimpanzee sanctuaries, it has to be mentioned that in order 
to capture one infant chimpanzee from their community in 
the natural habitat, poachers have to shoot three to five 
adults. The adults are used for commercial/domestic 
bushmeat trade while the babies are sold for pet trade. The 
latter are those ending in many cases in sanctuaries 
throughout Africa. Capturing of wild chimpanzees is strictly 
forbidden in all great ape range countries but still every year 
many infant chimpanzees are confiscated from illegal dealers 
or private owners. Between 2001 and 2005, 5 to 95 infant 
chimpanzees were received through confiscations per year in 
19 Pan African Sanctuary Alliance (PASA) primate 
sanctuaries though the trend is declining in the last years 
(PASA, unpublished data). The age of rescued infant 
chimpanzees ranges from one to five years with some being 
rescued after staying with their illegal owners for two to 
three years. 
 Here we show investigations on the prevalence of SIV, 
STLV and SFV in wild-born chimpanzees of the Eastern 
subspecies (P. t. schweinfurthii) at the Ngamba Island 
Chimpanzee Sanctuary (NICS), Uganda. Animals originated 
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mainly from Uganda and the Democratic Republic of Congo 
and a few from Rwanda (Table 1). Furthermore we provide 
molecular data on the SFV strains detected. 
MATERIALS AND METHODS 
 The chimpanzee sanctuary started in 1998 and is located 
on Ngamba Island (S 000 06/E 32°39, 0.46 km2, 1160 m 
above sea level). Chimpanzees were brought to the sanctuary 
after being rescued from illegal traders and poachers. The 
island is 100 hectares of secondary rain forest, lies 23 km off 
Entebbe in the north-west of Lake Victoria, and is part of the 
Koome group of islands in the Mukono District, Uganda. 
The samples investigated in this study were obtained from 
38 orphan chimpanzees in semi-captive management at 
NICS, following research approval from the relevant 
national authorities. The individuals tested consist of 21 
females and 17 males. Table 1 summarizes the age at the 
time of introduction into the sanctuary and origin of the 
chimpanzee. Apart from the initial group of 17 chimpanzees 
that had lived together before being brought to the island, 
Table 1. Name, Origin, Sex and Results of Foamy Virus PCR of Chimpanzees on Ngamba Island 
 
Name Sex 
Est. Yr of 
Birth 
Age (yrs)  
by 2007 





Kidogo Female 1984 23 1998 Congo  - - 
Sophie Female 1986 21 1998 Congo  - - 
Katie Female 1987 20 1998 Congo  - - 
Ikuru Female 1995 12 1999 Congo  + + 
Billi Female 1998 10 2001 Congo  - + 
Mukisa Female 1998 9 2001 Congo  - + 
Ndyakira Female 1999 8 2002 Congo  - - 
Nakuu Female 2001 6 2003 Congo  + + 
Peace Female 1986 21 1998 Uganda  (+) (+) 
Connie Female 1989 18 1998 Uganda  - + 
Bahati Female 1990 17 1998 Uganda  - - 
Natasha Female 1990 17 1998 Uganda  - + 
Becky Female 1991 16 1998 Uganda  - + 
Sally Female 1991 16 1998 Uganda  - - 
Cindy Female 1993 14 1998 Uganda  - (+) 
Nkumwa Female 1996 11 1998 Uganda  - (+) 
Kazahukire Female 1999 8 2002 Uganda  + + 
Kyewunyo1 Female 2002 5 2002 Uganda  - + 
Megan Female 1984 23 1998 Rwanda  - (+) 
Nagoti Female 1986 21 1998 Unknown - + 
Nani Female 2001 6 2002 Unknown + + 
Masiko Male 1984 23 1998 Congo  + + 
Sunday Male 1987 20 1998 Congo  - + 
Robbie Male 1986 21 1998 Congo  - + 
Mawa Male 1996 11 1999 Congo  + + 
Kalema Male 1996 11 1999 Congo  - - 
Umutama Male 1996 11 1999 Congo  + + 
Umugezi Male 1997 10 1999 Congo  - + 
Baluku Male 1998 9 1999 Congo  - + 
Asega Male 1998 9 2000 Congo  - + 
Kisembo Male 1999 8 2000 Congo  - - 
Indi Male 1999 8 2001 Congo  - (+) 
Okech Male 2001 7 2003 Congo  - + 
Rambo Male 2004 3 2006 Congo  - - 
Tumbo Male 1989 18 1998 Uganda  - - 
Mika Male 1992 15 1998 Uganda  - + 
Bwambale Male 1999 7 2002 Uganda  + + 
Rutoto Male 2004 3 2006 Uganda  - + 
1 Kyewunyo is captive born. 
( ) sequences not analyzable. 
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most of the chimpanzees arrived at the sanctuary at the age 
range from three to five years. The chimpanzees underwent a 
three-month quarantine period but no serological or PCR 
analyses were done to screen for viral pathogens. 
 During an annual medical health check in February, 
2007, blood was collected from all chimpanzees under 
general anesthesia. Whole blood (10 ml) was taken by 
inguinal venipuncture using CPT Vacutainer tubes. 8 ml of 
blood was centrifuged at 1600 g (2800 rpm) for 30 minutes. 
Two aliquots of the buffy coat were refrigerated at 4°C for 15 
minutes and then stored in cryotubes in liquid nitrogen at the 
Uganda Virus Research Institute till transported on dry ice to 
the Robert Koch-Institut in Berlin/Germany for analysis. 
Serum was stored at -20°C. The permit to export biological 
samples from endangered species was obtained from Uganda 
and German offices for the Convention on International 
Trade in Endangered Species (CITES). 
 DNA was extracted from the buffy coat using the 
QIAamp DNA Blood Min Kit (Qiagen, Hilden, Germany). 
Amplification of SFV proviral genomic region (425 bp; 6086 
- 6492 on SFV reference sequence NC_001364) was 
performed using generic primers targeting the viral integrase 
(int) region as previously described [6]. Standard PCR 
conditions were used for both rounds of amplification with 
the exception of the annealing temperatures of 60°C for 45 
cycles for the first round and 55°C for 45 cycles for the 
second round, respectively. Generic and nested PCR 
products were visualized in 1.5% agarose gels stained with 
ethidium bromide under UV light. 
 The purified PCR products were sequenced in both 
directions with PCR primers using the BigDye terminator 
cycle kit (Applied Biosystems, Darmstadt, Germany) on an 
ABI Prism 3100 automated sequencer (Applied Biosystems). 
 Sequences were aligned with the ClustalW program, 
manually edited and imported into PHYLIPversion3.67 
(http://evolution.genetics.washington.edu/phylip.html). The 
following reference sequences were used: GenBank 
accession numbers were AY686179, AY583781; 
AY278782, X83293, AY686201, X83290, DQ354075, 
DQ354089, X83292; AY686203, AY686206, AY195688, 
AY278792, AY278776, AF049086, AY686195, AY195685, 
X83297, AY195682, X83296, AY639122, AY639141, 
AY639133, EU527588, AY639136, AY639123, AY639124, 
AY639138, AY639128, AY639130; EU527540, EU527532, 
X83294, EU527541, EU527501, EU527498, EU527637, 
AY195676, AY195675, EU527499, EU527496, EU527534, 
EU527502, X83298. Distance-based trees were generated 
using the Kimura two-parameter model in conjunction with 
the Neighbor Joining (NJ) and minimum-evolution methods 
in the PHYLIP software package [7]. The topology of the 
tree was confirmed by Maximum Likelihood analyses. The 
reliability of the inferred tree was evaluated by bootstrap 
analysis on 1000 replicates. 
 For serological analyses a commercially available 
enzyme immunoassay kit for the detection of antibodies 
against human T-lymphotropic virus types I and II (HTLV-
I/-II) was used (Murex Biotech Limited, Dartford, UK) 
according to the manufacturer’s instructions. This test has 
been shown to efficiently detect STLV-1 in wild  
 
chimpanzees [5]. Simian Immunodeficiency Virus (SIV) 
antibody detection was performed using the Murex HIV-
1.2.0 kit (Abbott Murex Biotech Limited) according to the 
manufacturer’s instructions and the GENESCREEN HIV 1.2 
version 2 (BIO-RAD, München, Germany) which were 
designed for the detection of antibodies directed against 
human immunodeficiency virus and is widely used for 
detection of SIV in non-human primates (data will be shown 
elsewhere). 
RESULTS AND DISCUSSION 
 DNA samples from 38 chimpanzees were available, 28 
(73.7%) were positive for SFV by PCR (Table 1). All serum 
samples were negative for HIV and HTLV/STLV antibodies. 
These results showed that none of the chimpanzees in the 
sanctuary was infected with SIV or STLV. 
 Int sequences from 23 out of 28 chimpanzee blood 
samples positive for SFV DNA could be used for sequence 
analysis. Five sequences were of poor quality due to low 
PCR signal and were therefore not included in this analysis. 
The nucleotide sequences obtained in this study were 
submitted to GeneBank (NCBI) and published under the 
accession numbers EU239510-EU239533. 
 Phylogenetic tree analysis was performed with the NJ 
method using the 23 SFV sequences generated in this study 
and published relevant SFV sequences from all chimpanzee 
subspecies, as well as from gorilla, bonobo, orangutan, 
African and Asian monkeys and one sequence of an SFV-
infected human [4, 6, 8-10]. 
 The obtained sequences group fell within the SFV clade 
of the Eastern chimpanzee subspecies (P. t. schweinfurthii) 
(Fig. 1). The subspecies status of the chimpanzees studied 
plus their genetic diversity and association was established 
as P. t. schweinfurthii by analysis of mtDNA (data not 
included here). Within this clade, the 23 SFV sequences 
grouped in four subclusters with other recently published 
SFV strains from East African chimpanzee subspecies. 
While 22 sequences grouped in subclusters 1 to 3, one strain 
obtained from the individual “Umutama” clusters with 
recently published sequences obtained from wild 
chimpanzees in subcluster 4. 
 SFV strains from some individuals were genetically more 
closely related than others. The SFV strain from “Robbie”, a 
former alpha male of the community, forms a subcluster with 
SFV strains from the chimpanzees “Kyewunyo”, “Connie”, 
“Baluku”, “Umugezi” and “Nagoti” with 99.5 to 100.0 % 
nucleotide identity. “Mika”, the current alpha male, has 99% 
to 100% nucleotide identity with “Rutoto”, one of the new 
infant arrivals at the sanctuary, and “Becky”. Also sequences 
of “Sunday”, “Masiko” and “Ikuru” showed 99.9% 
nucleotide identity. It is noteworthy to mention that “Ikuru” 
has been frequently bitten by the other two chimpanzees. 
Further investigations should show whether SFV-positive 
individuals are infected with more than one strain. 
 Sanctuary chimpanzees are usually living in a limited 
habitat forming a large community, which leads to a high 
aggression level. In contrast to the natural situation, the 
individuals have no alternative to keeping out of a conflict or 
avoiding further conflicts by staying at a distance of each  
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Fig. (1). Phylogenetic analysis of int sequences from SFV-infected chimpanzees of Ngamba and selected published sequences from four 
chimpanzee subspecies. The species’ origins for the chimpanzee SFV sequences used are indicated. The phylogeny is based on the 
Neighbour-joining method using 2 Kimura distances performed in PHYLIP3.67 and the reliability of the inferred tree was evaluated by 
bootstrap analysis on 1000 replicates. The topology of the tree was confirmed by Maximum Likelihood Method. The scale bar represents an 
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other. Aggressions are mostly associated with fighting 
leading to scratches and also deep bite wounds. Such injuries 
might play an important role in transmission of pathogens [8, 
11]. In sanctuaries this may contribute to multiple infections 
with strains with different genetic background. More 
analyses are needed to establish the frequency of infections 
with multiple SFV strains possibly resulting in virus 
recombination. 
 The SFV strains in this study showed a relatively high 
diversity and could be grouped into four main clusters. 
However, no clustering according to the geographic origin of 
the chimpanzees was found. The comparison of the strains 
described here with recently published SFV strains from 
wild P. t. schweinfurthii from Uganda, Congo and Tanzania 
[4] could also not identify clustering by geographical origin. 
These results are consistent with previous findings [4] which 
could not show region-specific clusters of SFV strains within 
one chimpanzee subspecies. However, this study shows in 
principle the possibility of pathogen introduction to great ape 
communities in sanctuaries which can cause co-infections 
with multiple virus strains. 
 This may have direct implications for sanctuary 
management since most apes are hand raised, and long-term 
interactions of animals and keepers with bites and scratches 
are frequently observed. In order to avoid pathogen 
transmission to humans, special precautions are needed, 
especially in sanctuaries where apes are SIV positive. 
Another concern may be that most sanctuaries aim at 
reintroducing great apes into the wild. The impact of these 
viruses on wild primates, which can again mix with regional 
strains, is unknown. 
 All wild-born captive chimpanzees on Ngamba Island 
were negative for SIV/HIV and STLV-1 and -2 antibodies, 
which might not reflect the situation in other ape sanctuaries 
in Africa. With the most recent findings that SIVcpz is 
pathogenic in free-ranging chimpanzees [1] it is obvious that 
all newly arriving chimpanzees at sanctuaries should be 
screened for defined pathogens including SIV. This will not 
only protect the health of the chimpanzee in the groups but 
also minimize the risk of infection for people in close contact 
with the animals. Furthermore, future reintroduction 
programs might benefit from such programs as only healthy 
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